Henry Waxman Writes a Letter — Wipes Out $18 Billion of Biotech Market Value

The New York Times reports that Rep. Henry Waxman and three Democratic colleagues wrote a letter protesting the price of Gilead’s new hepatitis drug, Sovaldi. A twelve-week course of Sovaldi costs $84,000 — about $1,000 per pill. “Our concern is that a treatment will not cure patients if they cannot afford it,” the congressmen said […]



via John Goodman's Health Policy Blog http://ift.tt/1jCJzSs